Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Krsnaa Diagnostics's share price for the quarter that ended in Mar. 2026 was ₹520.3. Krsnaa Diagnostics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 32 Mil. Therefore, Krsnaa Diagnostics's market cap for the quarter that ended in Mar. 2026 was ₹16,878 Mil.
Krsnaa Diagnostics's quarterly market cap
declined
from Sep. 2025 (₹24,550 Mil) to Dec. 2025 (₹23,400 Mil) and
declined
from Dec. 2025 (₹23,400 Mil) to Mar. 2026 (₹16,878 Mil).
Krsnaa Diagnostics's annual market cap
increased
from Mar. 2024 (₹19,845 Mil) to Mar. 2025 (₹25,441 Mil) but then
declined
from Mar. 2025 (₹25,441 Mil) to Mar. 2026 (₹16,878 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Krsnaa Diagnostics's Enterprise Value for Today is ₹19,644 Mil.
Krsnaa Diagnostics (NSE:KRSNAA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Krsnaa Diagnostics Market Cap Related Terms
Krsnaa Diagnostics Market Cap Historical Data
* Premium members only.
The historical data trend for Krsnaa Diagnostics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:KRSNAA vs TMO, DHR, IDXX: Market Cap Comparison
For the Diagnostics & Research subindustry, Krsnaa Diagnostics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krsnaa Diagnostics Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Krsnaa Diagnostics's Market Cap distribution charts can be found below:
* The bar in red indicates where Krsnaa Diagnostics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Krsnaa Diagnostics's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krsnaa Diagnostics (NSE:KRSNAA) has a Market Cap of ₹18,221 Mil as of Jul. 06, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Krsnaa Diagnostics and its competitors. According to the industry distribution chart, Krsnaa Diagnostics ranks #84 out of 219 companies in the Medical Diagnostics & Research industry, placing it in the top 38.4%.
Is Krsnaa Diagnostics' Market Cap too high?
Krsnaa Diagnostics' current Market Cap is ₹18,221 Mil. Based on the distribution chart, Krsnaa Diagnostics ranks #84 out of 219 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Krsnaa Diagnostics has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Krsnaa Diagnostics' Market Cap compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Krsnaa Diagnostics ranks #84 out of 219 companies for Market Cap. This puts Krsnaa Diagnostics in the upper half of its industry. The industry median Market Cap is 59.06. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 59.06, based on 219 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Krsnaa Diagnostics and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 59.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krsnaa Diagnostics's current Market Cap is ₹18,221 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krsnaa Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Krsnaa Diagnostics (NSE:KRSNAA) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹902.48, compared to a current price of ₹562.85 — trading 37.6% below its estimated fair value. The current Market Cap is ₹18,221 Mil. Krsnaa Diagnostics' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Krsnaa Diagnostics (NSE:KRSNAA), the current Market Cap is ₹18,221 Mil as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krsnaa Diagnostics (NSE:KRSNAA) Overvalued in 2026?
Based on GuruFocus' analysis, Krsnaa Diagnostics stock appears to be undervalued.
The current stock price of ₹562.85 is trading 37.6% below its estimated GF Value™ of ₹902.48.
GuruFocus considers Krsnaa Diagnostics to be Significantly Undervalued.
Key valuation signals for NSE:KRSNAA:
Market Cap: ₹18,221 Mil
GF Value™: ₹902.48 vs. price of ₹562.85 (37.6% below fair value)
No single metric tells the full story. See the NSE:KRSNAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krsnaa Diagnostics Ltd is a diagnostic services provider, both in Radiology and Pathology. It offers a wide range of diagnostic services such as imaging/radiology services, routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The company's operations predominantly relate to providing Radiology and Pathology services for X Ray, CT Scan, MRI, Mammography, tele-reporting services, and all types of Blood and Urine investigations.
75GF Score
Get the complete analysis for NSE:KRSNAA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KRSNAA has been successfully added to your 
